ASSTStrive, Inc.

Ticker: ASST | Current Price: $29.30 | Today's Change: +8.28% Filing: Form 8-K (Item 8.01) | Filed with the SEC on: October 21, 2026

---

What Happened

Strive, Inc. filed an 8-K with the SEC on October 21, 2026, disclosing financial results for its second quarter of fiscal year 2026. Revenue from contracts with customers came in at $2,934,000 for Q2 FY2026, a dramatic increase compared to the $217,807 reported in Q2 FY2025. Despite that top-line growth, the company recorded a net loss of $3,749,000 and an operating loss of $7,763,000 for the quarter, with basic and diluted earnings per share both at -$5.52.

---

Why It Matters

The near-tripling — and then some — of revenue year-over-year is a meaningful signal that Strive's business has scaled materially since the same period last year. However, the operating loss of nearly $7.8 million dwarfs the $2.93 million in revenue, making clear that the company is still spending well ahead of what it earns. For investors, the practical picture is one of rapid top-line growth paired with significant cash consumption — a dynamic typical of early-stage companies investing heavily in infrastructure, headcount, or market expansion. The stock's 8.28% gain on the day suggests the market is focusing on the revenue trajectory rather than the loss magnitude, at least in the near term.

---

Analysis

The revenue jump from roughly $218,000 to nearly $2.93 million in a single year is the headline number here, and it is genuinely notable — it represents more than a 13-fold increase. That kind of growth rate, if sustained, would validate the early investment thesis around Strive's model. That said, the gap between revenue and operating loss is wide: at -$7.76 million in operating income against $2.93 million in revenue, the operating loss ratio is deeply negative, which means the company needs to either grow revenue substantially further or pull back on spending — or both — to approach any path toward operating profitability.

The EPS figure of -$5.52 on a basic and diluted basis is also worth watching as share count evolves. For context, this filing comes roughly seven weeks after StockWatch's initiating coverage on ASST was published in September 2026; that existing coverage provides a fuller fundamental framework for the stock.

Key things to watch going forward:

• Revenue sustainability: Can the Q2 FY2026 revenue run-rate be maintained or grown into Q3 and beyond?
• Operating cost trajectory: Is the $7.76 million operating loss a peak investment phase, or is it expanding proportionally with the business?
• Cash position: Not disclosed in the structured facts provided from this filing — investors should look for balance sheet detail in any accompanying materials.
• Share count and dilution: The -$5.52 EPS figure implies a relatively small share count; any future capital raises could be dilutive.

---

Disclaimer

This report is a news and informational summary of a public SEC filing and does not constitute investment advice, a solicitation to buy or sell any security, or an equity research recommendation. No rating or price target is expressed or implied. Investors should conduct their own due diligence and consult a qualified financial adviser before making investment decisions.

Existing Coverage

StockWatch has full coverage on ASST, published 2026-09-04. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-21. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1920406/000162828026066608/asst-20261021.htm